Ford Chandra L, Cook Mekeila C, Cross Rebecca Israel
Behavioral, Social & Health Education Sciences, Rollins School of Public Health and African American Studies, Emory College of Arts and Sciences, Emory University, Atlanta, GA 30322, United States.
Department of Public Health, School of Global Health, Meharry Medical College, Nashville, TN 37208, United States.
Epidemiol Rev. 2024 Sep 16;46(1):1-18. doi: 10.1093/epirev/mxae005.
People living with HIV can achieve viral suppression through timely HIV care continuum (HCC) engagement (ie, diagnosis, linkage to HIV care, retention in care, and adherence to prescribed treatment regimens). Black populations have poorer viral suppression, suboptimal HCC engagement, and higher levels of racism-related mistrust. The state of the evidence linking suboptimal HCC engagement to racism among US Black populations is assessed in this article. Using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, 6 English language databases were searched using 3 sets of key terms related to HCC engagement (eg, HIV diagnosis), racism (eg, discrimination), and the population (eg, Black people). To exclude articles, 3 rounds of reviews were conducted and results assessed for interrater reliability (κ = 99.00%; P < 0.00). From 2027 articles initially retrieved, the final set of analyses (n = 32) included clinical and nonclinical samples of people living with or at risk for HIV. Overall, the evidence was conceptually robust but methodologically simple. Studies primarily targeted intrapersonal and interpersonal racism and the late stage of HCC engagement: adherence. Sample-specific prevalence of racism ranged considerably; for example, 20% to 90% of sample members in clinical settings perceived or experienced interpersonal forms of racism. To date, the evidence suggests the relationship between racism and HCC engagement is mixed. Racism is salient among Black people living with or at risk for HIV. It appears not to impede HIV testing, though it may limit retention in HIV care, especially among men who have sex with men.
艾滋病毒感染者可以通过及时参与艾滋病毒治疗连续过程(HCC)(即诊断、与艾滋病毒治疗建立联系、持续接受治疗以及坚持规定的治疗方案)来实现病毒抑制。黑人人群的病毒抑制情况较差,HCC参与度欠佳,且与种族主义相关的不信任程度较高。本文评估了美国黑人群体中HCC参与度欠佳与种族主义之间的证据状况。按照系统评价和荟萃分析的首选报告项目指南,使用与HCC参与(如艾滋病毒诊断)、种族主义(如歧视)和人群(如黑人)相关的3组关键词,对6个英文数据库进行了检索。为排除文章,进行了三轮评审,并对结果进行了评分者间信度评估(κ = 99.00%;P < 0.00)。从最初检索到的2027篇文章中,最终分析集(n = 32)包括了艾滋病毒感染者或有感染风险者的临床和非临床样本。总体而言,证据在概念上很充分,但方法上很简单。研究主要针对个人内和人际间的种族主义以及HCC参与的后期阶段:坚持治疗。种族主义在特定样本中的患病率差异很大;例如,临床环境中20%至90%的样本成员察觉到或经历过人际形式的种族主义。迄今为止,证据表明种族主义与HCC参与之间的关系喜忧参半。种族主义在感染艾滋病毒或有感染风险的黑人中很突出。它似乎并不妨碍艾滋病毒检测,不过可能会限制在艾滋病毒治疗中的持续参与,尤其是在男男性行为者中。